ACPAs have been hypothesized to function through the formation of immune complexes (IC) between ACPA and their citrullinated ligand, and a set of fine specificities for these ligands has recently been reported for SE-bearing RA patients [13]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.